Visit the institution website for COVID‑19 updates
Medical degree (MBBS or equivalent) or a 2.1/first degree (or overseas equivalent) in relevant bioscience subject. Non-traditional qualifications will be considered on an individual basis.
Months of entry
The first course of its kind in the UK, the Stem Cell & Regenerative Therapies: From Bench to Market MSc combines biological and medical science with business, law and bioethics. It is designed to develop expertise in the biological, commercial and regulatory aspects of cellular therapy, along with its application in biomedicine and equips students to pursue a business-based career in cellular therapy or related disciplines.
The complexity of issues relating to cell manufacturing, the underlying regulatory framework, reimbursement and viable business models all represent challenges that severely undermine the timing and the delivery of a sustainable healthcare model. Our programme will equip you with the knowledge that will enhance the understanding of these complex issues within an integrated and commercial context.
This one-year advanced study course explores the biological, regulatory and business aspects of cellular therapy in the fields of biomedicine. You will study a range of modules that include Stem Cells in Cellular Therapies & Regenerative Medicine and Cellular Therapies in Immunology. You will also complete a dissertation related to business strategy development for cellular therapy.
You will study modules totalling 180 credits throughout the year, with 60 credits coming from the 15,000 – 18,000-word dissertation.
Qualification, course duration and attendance options
- full time12 months
- Campus-based learningis available for this qualification
Course contact details
- Admissions Office